Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Liang‐Hao Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7535-7475; OpenAlex author ID A5019238809. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 9

  1. A machine learning-based interpretable model for predicting pancreatic cancer in chronic pancreatitis patients with focal pancreatic lesions. Last author DOI 10.1186/s12885-026-16234-5↗
  2. Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database. Last author DOI 10.3389/fonc.2022.1026268↗
  3. SPINK1 mutations and risk of pancreatic cancer in a Chinese cohort. Co-author DOI 10.1016/j.pan.2021.05.304↗
  4. Study of underlying pancreatic cancer could be improved. Last author DOI 10.1016/j.hpb.2019.12.015↗
  5. Design flaws in statins and pancreatic cancer research. Last author DOI 10.1002/ijc.32352↗
  6. Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: A cohort of 1656 patients. Last author DOI 10.1016/j.dld.2017.07.001↗
  7. Pancreatic cancer in patients with recently diagnosed chronic pancreatitis. Co-author DOI 10.1038/ajg.2015.107↗
  8. Chronic pancreatitis and pancreatic cancer. First author DOI 10.1053/j.gastro.2014.03.054↗
  9. Incidence of pancreatic cancer in chinese patients with chronic pancreatitis. Co-author DOI 10.1159/000322982↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhao‐Shen Li · 5 shared papers, 2014–2020 · strength 0.48
  2. Ya‐Wei Bi · 2 shared papers, 2017–2026 · strength 0.34
  3. Jin‐Hui Yi · 1 shared paper, 2026 · strength 0.29
  4. Zhuan Liao · 3 shared papers, 2011–2021 · strength 0.20
  5. Zhaoshen Li · 2 shared papers, 2011–2022 · strength 0.20
  6. Bai‐Rong Li · 3 shared papers, 2014–2017 · strength 0.20
  7. Wen‐Bin Zou · 2 shared papers, 2017–2021 · strength 0.18
  8. Dan Wang · 1 shared paper, 2022 · strength 0.17
  9. Ren-Qian Huang · 1 shared paper, 2022 · strength 0.17
  10. Tao Zhang · 1 shared paper, 2020 · strength 0.15
  11. Liu Yu · 1 shared paper, 2020 · strength 0.15
  12. Yu Liu · 1 shared paper, 2019 · strength 0.14
  13. Nan Ru · 1 shared paper, 2021 · strength 0.13
  14. Lei Wang · 1 shared paper, 2021 · strength 0.13
  15. Zhao‐Shen Li · 1 shared paper, 2021 · strength 0.13
  16. Lu Hao · 1 shared paper, 2017 · strength 0.05
  17. Jie Chen · 1 shared paper, 2011 · strength 0.02
  18. Luo‐Wei Wang · 1 shared paper, 2011 · strength 0.02
  19. Zhendong Jin · 1 shared paper, 2011 · strength 0.02
  20. Xianbao Zhan · 1 shared paper, 2011 · strength 0.02
  21. Wei Wang · 1 shared paper, 2011 · strength 0.02
  22. Duowu Zou · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.